This blog is a collection of my favorite new treatments for gastric cancer currently available through clinical trials. The start of each post contains a brief description of the approach, reasons I included it and a link to the trial website.

S-1: A Synergistic Drug Combination that Improves Overall Survival in Patients with Stage II and III Gastric Cancer

S-1 (TS-1) is a chemotherapeutic preparation combining tegafur, gimeracil and oteracil potassium in a molar ratio of 1:0.4:1 that significantly improves overall survival in patients with stage II or III gastric cancer. In this study, patients that… [Learn More…]

Trastuzumab: A Breast Cancer Drug Effective In Treating Advanced Gastric Cancer

Trastuzumab is a monoclonal antibody that has been significant in treating HER-2 breast cancers. Recently, it has been shown to prolong life in patients with a malignant epithelial condition. Since Trastuzumab also regulates angiogenesis and… [Learn More…]